Iomai - Worst Pharma Stocks of 2007
Company:Â Iomai
Starting stock price: $4.85
Ending stock price: $1.03
Percent Change: -78.76%
Details: Iomai reported in May that it's needle-free flu vaccine demonstrated less of an immune response than an injection, sending its stock down 35%. The company is also developing a patch for traveler's diarrhea that has delivered promising results, and is working on two immunostimulant patches for pandemic flu.
More News:
Iomai vax patch guards against traveler's diarrhea. Report
Vaccine-maker Iomai files $83M IPO. Report
More stories about Iomai
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: